McKenna Mark C. Insider Trades

Insider Trading History

Track insider trading activity for McKenna Mark C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $590k 8,026 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$582k 8,026 shares
$72.51
$73.52
Helix Acquisition II
Helix Acquisition II HLXB
other, Former Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$297k 30,000 shares
$9.90
$9.90
Helix Acquisition II
Helix Acquisition II HLXB
other, Former Director
Holding Value $297k 30,000 shares
Last Trade
Aug 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$297k 30,000 shares
$9.90
$9.90
Apogee Therapeutics
Apogee Therapeutics APGE
Director
Holding Value $1.22M 14,461 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$602k 14,461 shares
$41.66
$84.19
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $1.84M 25,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$389k 25,000 shares
$15.55
$73.52
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $144k 6,960 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 6,960 shares
$14.78
$20.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $223k 6,960 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 6,960 shares
$26.04
$32.11
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $673k 32,500 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$481k 32,500 shares
$14.80
$20.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $1.04M 32,500 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$840k 32,500 shares
$25.85
$32.11
Apogee Therapeutics
Apogee Therapeutics APGE
Director
Holding Value $1.68M 20,000 shares
Last Trade
Dec 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$886k 20,000 shares
$44.32
$84.19
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Director
Holding Value $2.33M 72,500 shares
Last Trade
Jul 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.36M 72,500 shares
$18.81
$32.11
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Director
Holding Value $1.5M 72,500 shares
Last Trade
Jul 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$638k 72,500 shares
$8.80
$20.70
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $0 0 shares
Last Trade
Feb 01, 2024 Sale
$12.3M 477,000 shares
$25.86
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $2.94M 40,000 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.03M 40,000 shares
$25.86
$73.52
Apogee Therapeutics
Apogee Therapeutics APGE
Director
Holding Value $12.6M 150,000 shares
Last Trade
Aug 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.54M 150,000 shares
$23.60
$84.19
Prometheus Biosciences
Prometheus Biosciences RXDX
Chairman, President And CEO
Holding Value $0 0 shares
Last Trade
Jun 16, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$441M 2,205,545 shares
$199.92
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chairman, President & CEO
Holding Value $32.2M 161,105 shares
Last Trade
Jun 02, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$24.4M 122,531 shares
$198.83
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chairman, President & CEO
Holding Value $35.6M 178,036 shares
Last Trade
Jun 02, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$24.4M 122,531 shares
$198.83
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chairman, President & CEO
Holding Value $56.7M 283,633 shares
Last Trade
Mar 15, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.89M 25,000 shares
$115.58
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chairman, President & CEO
Holding Value $11M 55,144 shares
Last Trade
Mar 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.9M 25,000 shares
$116.14
$199.92

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up